Literature DB >> 19536368

Allergic inflammation: where epithelial function interacts with immune response in atopic diseases.

Laura Godoy1.   

Abstract

Current hot topics in allergy and asthma were presented this year at the annual meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI) in Washington, D.C. Understanding the natural history of allergic diseases is an area of interest because it could help to identify relevant biomarkers to predict allergy early in infancy. An abnormal epithelial barrier allows easy access to allergens/ pathogens and such a dysfunction could also be involved in the initiation of the natural course of allergic diseases. In addition, newly identified cytokines produced by epithelial cells such as thymic stromal lymphopoietin, interleukin-33 (IL-33) and IL-25 are involved in the generation of T helper type 2 (Th2) cell response. Genetic studies are also providing relevant information on biomarkers and new targets for allergy and asthma. Different genetic studies to identify single nucleotide polymorphisms of relevant mediators of allergy in patients, application of gene array analysis to identify biomarkers during asthma exacerbation, and IL-13-induced inflammatory events, are some examples of the interesting information presented at the AAAAI this year. Copyright 2009 Prous Science, S.A.U. or its licensors. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19536368     DOI: 10.1358/dnp.2009.22.4.1368087

Source DB:  PubMed          Journal:  Drug News Perspect        ISSN: 0214-0934


  5 in total

1.  T cell-derived Act1 is necessary for IL-25-mediated Th2 responses and allergic airway inflammation.

Authors:  Shadi Swaidani; Katarzyna Bulek; Zizhen Kang; Muhammet Fatih Gulen; Caini Liu; Weiguo Yin; Amina Abbadi; Mark Aronica; Xiaoxia Li
Journal:  J Immunol       Date:  2011-08-19       Impact factor: 5.422

2.  Targeting the IL-1 family members in skin inflammation.

Authors:  Liselotte E Jensen
Journal:  Curr Opin Investig Drugs       Date:  2010-11

3.  Allergy as an epithelial barrier disease.

Authors:  Pirkko Mattila; Sakari Joenväärä; Jutta Renkonen; Sanna Toppila-Salmi; Risto Renkonen
Journal:  Clin Transl Allergy       Date:  2011-06-10       Impact factor: 5.871

4.  Pollen/TLR4 Innate Immunity Signaling Initiates IL-33/ST2/Th2 Pathways in Allergic Inflammation.

Authors:  Jin Li; Lili Zhang; Xin Chen; Ding Chen; Xia Hua; Fang Bian; Ruzhi Deng; Fan Lu; Zhijie Li; Stephen C Pflugfelder; De-Quan Li
Journal:  Sci Rep       Date:  2016-10-31       Impact factor: 4.379

5.  Protective barrier properties of Rhinosectan® spray (containing xyloglucan) on an organotypic 3D airway tissue model (MucilAir): results of an in vitro study.

Authors:  Barbara De Servi; Francesco Ranzini; Núria Piqué
Journal:  Allergy Asthma Clin Immunol       Date:  2017-08-10       Impact factor: 3.406

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.